Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B

BACKGROUND: Current treatment options for chronic hepatitis B (CHB) are pegylated interferon alpha and nucleoside analogues (NAs). NAs have relatively fewer side effects than interferon alpha, and generally well tolerated. Previously 12.9% of patients on telbivudine treatment were reported to develo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Gastroenterol
Asıl Yazarlar: Ying, Yue, Hu, Yue-Kai, Jin, Jia-Lin, Zhang, Ji-Ming, Zhang, Wen-Hong, Huang, Yu-Xian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889588/
https://ncbi.nlm.nih.gov/pubmed/29625557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-018-0773-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller